Shu Wang

机构：Central Hospital of Zibo · ORCID：0009-0005-3667-364X

发表论文 18 篇 · 总被引 130 次 · h-index 6

代表论文

• GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway (2016 · Scientific Reports · 被引 40)
• Activation of peroxisome proliferator-activated receptor–γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage (2016 · Journal of neurosurgery · 被引 27)
• Revising Host Phenotypes of Sepsis Using Microbiology (2021 · Frontiers in Medicine · 被引 23)
• Preparation of Dihydromyricetin-Loaded Self-Emulsifying Drug Delivery System and Its Anti-Alcoholism Effect (2023 · Pharmaceutics · 被引 18)
• Determination of the protein expression profiles of Propsilocerus akamusi (Tokunaga) Malpighian tubules response to cadmium stress by iTRAQ coupled LC–MS/MS (2017 · Journal of Proteomics · 被引 12)
• Mir-150-5p distinguishes acute pulmonary embolism, predicts the occurrence of pulmonary arterial hypertension, and regulates ox-LDL-induced endothelial cell injury (2024 · Hereditas · 被引 7)